He Could Barely Walk and Had to Give Up Golf. What Was Wrong?
Over six years, many doctors told the patient he had peripheral neuropathy. What they couldn ’t tell him was why — or how to treat it. (Source: NYT Health)
Source: NYT Health - June 30, 2022 Category: Consumer Health News Authors: Lisa Sanders, M.D. Tags: Golf Tests (Medical) Nerves and Nervous System Immune System Source Type: news

' Genetic' Height Linked to Peripheral Neuropathy, Other Disorders'Genetic' Height Linked to Peripheral Neuropathy, Other Disorders
' Genetic ' height, the height a person is predicted to reach independent of environmental influences, may be an underappreciated risk factor for a wide range of chronic conditions, new research suggests.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 9, 2022 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Longer-term Data from CARTITUDE-1 Study Demonstrate Continued Deep and Durable Responses to CARVYKTI ™ (ciltacabtagene autoleucel) in Heavily Pretreated Patients with Relapsed or Refractory Multiple Myeloma
CHICAGO, ILLINOIS, June 4, 2022 – – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today updated results from the Phase 1b/2 CARTITUDE-1 study evaluating the efficacy and safety of CARVYKTI™ (ciltacabtagene autoleucel; cilta-cel), a B-cell maturation antigen (BCMA)-directed chimeric antigen receptor T-cell (CAR-T) therapy. The study included patients with relapsed or refractory multiple myeloma (RRMM) who had received >3 lines of therapy including a proteasome inhibitor (PI), an anti-CD38 monoclonal antibody and an immunomodulatory agent (IMiD) or were double refractory to an IMiD and PI a...
Source: Johnson and Johnson - June 4, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news

Janssen to Highlight Science, Innovation and Advances in Robust Oncology Portfolio and Pipeline Through More Than 60 Data Presentations at ASCO and EHA
RARITAN, N.J., May 31, 2022 — The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that new research and data from its robust oncology portfolio and pipeline of investigational therapies will be presented at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place June 3-7 in Chicago, and the European Hematology Association (EHA) 2022 Congress taking place in Vienna, Austria, June 9-12. More than 60 presentations from company-sponsored studies across the two congresses, including 14 oral presentations, will feature new data and updates for both approved and investigation...
Source: Johnson and Johnson - May 31, 2022 Category: Pharmaceuticals Source Type: news

Roche ’s Polivy combination approved by European Commission for people with previously untreated diffuse large B-cell lymphoma
First new treatment option in more than 20 years to show a clinically meaningful improvement in progression-free survival is approved for people with previously untreated diffuse large B-cell lymphoma (DLBCL)Approval is based on pivotal data from the phase III POLARIX study, where Polivy plus R-CHP significantly improved progression-free survival with comparable safety versus the standard of care, R-CHOPFirst-line treatment with Polivy plus R-CHP has the potential to reduce the burden on patients and healthcare systems, associated with disease progression ¹Basel, 25 May 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today anno...
Source: Roche Investor Update - May 25, 2022 Category: Pharmaceuticals Source Type: news

Roche ’s Polivy combination approved by European Commission for people with previously untreated diffuse large B-cell lymphoma
First new treatment option in more than 20 years to show a clinically meaningful improvement in progression-free survival is approved for people with previously untreated diffuse large B-cell lymphoma (DLBCL)Approval is based on pivotal data from the phase III POLARIX study, where Polivy plus R-CHP significantly improved progression-free survival with comparable safety versus the standard of care, R-CHOPFirst-line treatment with Polivy plus R-CHP has the potential to reduce the burden on patients and healthcare systems, associated with disease progression ¹Basel, 25 May 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today anno...
Source: Roche Media News - May 25, 2022 Category: Pharmaceuticals Source Type: news

Roche ’s Polivy combination approved by European Commission for people with previously untreated diffuse large B-cell lymphoma
First new treatment option in more than 20 years to show a clinically meaningful improvement in progression-free survival is approved for people with previously untreated diffuse large B-cell lymphoma (DLBCL)Approval is based on pivotal data from the phase III POLARIX study, wherePolivy plus R-CHP significantly improved progression-free survival with comparable safety versus the standard of care, R-CHOPFirst-line treatment withPolivy plus R-CHP has the potential to reduce the burden on patients and healthcare systems, associated with disease progression1Basel, 25 May 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announce...
Source: Roche Investor Update - May 25, 2022 Category: Pharmaceuticals Source Type: news

Are my pills causing my hands and feet to throb? DR MARTIN SCURR answers your health questions
DR MARTIN SCURR: Burning sensations affecting the feet are typically due to nerve damage in the legs, known as peripheral neuropathy. (Source: the Mail online | Health)
Source: the Mail online | Health - May 17, 2022 Category: Consumer Health News Source Type: news

Did I Miss a Better Peripheral Neuropathy Treatment? Did I Miss a Better Peripheral Neuropathy Treatment?
After Medscape readers offered their opinions on his management of a patient with diabetic peripheral neuropathy, Dr Charles Vega took a closer look at two unique alternatives.Medscape Family Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 12, 2022 Category: Consumer Health News Tags: Family Medicine/Primary Care Clinical Case Source Type: news

More Anxiety Ups Peripheral Neuropathy Risk in Breast Cancer More Anxiety Ups Peripheral Neuropathy Risk in Breast Cancer
Depression, however, does not appear to affect chemotherapy-induced peripheral neuropathy risk. The study was published on as a preprint and has not yet been peer reviewed.First Look (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 4, 2022 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

'Moderate' alcohol intake could cause peripheral neuropathy warns expert - key risks
THE RAMIFICATIONS of alcohol abuse have been studied at length, with research suggesting there is no healthy level of consumption. There is proof that prolonged drinking is a great cause of cancer, heart disease and stroke. Some lesser-known risks, such as peripheral neuropathy, may result from moderate alcohol intake. (Source: Daily Express - Health)
Source: Daily Express - Health - April 30, 2022 Category: Consumer Health News Source Type: news

Carol Kirkwood on permanent nerve damage after 'horrific' accident - peripheral neuropathy
CAROL KIRKWOOD is the recognisable face of weather on BBC breakfast. Her bubbly yet professional manner has meant that Kirkwood has become somewhat known, having taken part in Strictly Come Dancing back in 2015. The star has also spoken out about how she has been affected both mentally and physically due to a traumatic bike accident back in 2020. (Source: Daily Express - Health)
Source: Daily Express - Health - April 12, 2022 Category: Consumer Health News Source Type: news

Covid patients may be ‘three times more likely’ to experience neuropathy - ‘could persist’
CORONAVIRUS has shattered the lives of millions in the two years since the pandemic was declared. But researchers are still in the process of mapping out its characteristics. In a recent analysis, it emerged that 30 percent of patients infected with the virus suffered some form of peripheral neuropathy. (Source: Daily Express - Health)
Source: Daily Express - Health - March 27, 2022 Category: Consumer Health News Source Type: news

Evaluation of peripheral neuropathy in lower limbs of patients with rheumatoid arthritis and its relation to fall risk - de Ara újo Pereira F, de Almeida Lourenço M, de Assis MR.
BACKGROUND: Rheumatoid Arthritis (RA) is a chronic disabling systemic disease characterized by joint inflammation, and extra-articular manifestations, including peripheral neuropathy, a condition that can be associated with changes in muscle strength, prop... (Source: SafetyLit)
Source: SafetyLit - March 25, 2022 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Her Burning Feet: What to Try Next for Peripheral Neuropathy Her Burning Feet: What to Try Next for Peripheral Neuropathy
Dr Charles Vega ' s patient has persistent, painful neuropathy of her feet. After several treatment failures, what ' s left?Medscape Family Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 24, 2022 Category: Consumer Health News Tags: Family Medicine/Primary Care Clinical Case Source Type: news